The CSL Limited (ASX:CSL) share price is falling

The CSL Limited (ASX: CSL) share price is down 0.9% to $185.78 at the time of writing after a succession of declines since September – but the S&P/ASX 200 declines are not where CSL finds itself most at home.

The one-year return on CSL shares is still 29.78%, but investors acclimatised to its consistent inclines could be excused for being slightly nervous about the CSL share price over the last two months.

For most healthcare-focused investors, CSL is the ultimate holding, with the biopharmaceutical giant considered one of the highest-quality businesses on the ASX and long-term growth in its plasma and influenza business units almost guaranteed.

The recent slow down in price is likely a response to bearishness in the overall market of late, and CSL still manages to outpace sector peer Cochlear Limited (ASX: COH) in terms of value and growth, with the Cochlear share price down today at $172.07.

ResMed Inc (ASX: RMD) is another option to consider in healthcare and its also in a share price slump right now.

Japanese Billionaire’s Prediction Will Give You Goosebumps

When a veritable investing and entrepreneurial genius speaks, it pays to listen.

In fact, he's now preparing a $100B "war chest" to invest entirely in this "terrifying" new technology, which could spell huge profits for investors.

Click here to learn about this technology and how you can profit!

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!